CG
RMD icon

Carmignac Gestion’s ResMed RMD Stock Holding History

Carmignac Gestion’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,376
Closed -$1.24M – 151
2023
Q3 		$1.24M Sell
8,376
-15,263
-65% -$2.76M 0.02% 114
2023
Q2 		$5.16M Sell
23,639
-10,257
-30% -$2.29M 0.09% 73
2023
Q1 		$7.38M Buy
33,896
+809
+2% +$176K 0.12% 63
2022
Q4 		$6.9M Buy
33,087
+350
+1% +$76.9K 0.12% 63
2022
Q3 		$7.15M Buy
32,737
+7,668
+31% +$1.75M 0.15% 54
2022
Q2 		$5.28M Sell
25,069
-5,578
-18% -$1.19M 0.11% 62
2022
Q1 		$7.5M Sell
30,647
-6,101
-17% -$1.48M 0.12% 59
2021
Q4 		$9.59M Buy
36,748
+15,181
+70% +$3.94M 0.13% 64
2021
Q3 		$5.69M Buy
21,567
+1,400
+7% +$383K 0.07% 86
2021
Q2 		$4.97M Sell
20,167
-6,607
-25% -$1.39M 0.06% 93
2021
Q1 		$5.15M Buy
26,774
+12,973
+94% +$2.6M 0.06% 86
2020
Q4 		$2.92M Buy
13,801
+578
+4% +$115K 0.03% 96
2020
Q3 		$2.27M Buy
13,223
+122
+0.9% +$22.5K 0.03% 91
2020
Q2 		$2.51M Buy
13,101
+3,959
+43% +$648K 0.03% 83
2020
Q1 		$1.35M Buy
9,142
+5,295
+138% +$843K 0.02% 89
2019
Q4 		$596K Buy
3,847
+1,791
+87% +$258K 0.01% 104
2019
Q3 		$278K Buy
2,056
+89
+5% +$11.7K ﹤0.01% 110
2019
Q2 		$240K Buy
+1,967
New +$218K ﹤0.01% 108

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Carmignac Gestion's RMD Position: Q4 2023 in Review

Carmignac Gestion sold out of ResMed (RMD) in Q4 2023, closing a stake of 8,376 shares — an estimated $1.24M sold.

Carmignac Gestion first reported a position in RMD in Q2 2019 and held it in 18 quarters. The position peaked at $9.59M in Q4 2021. 688 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

  • Carmignac Gestion reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
  • Carmignac Gestion sold 8,376 ResMed shares in Q4 2023, an estimated $1.24M.
  • Carmignac Gestion first reported a position in ResMed in Q2 2019 and held it in 18 quarters.
  • Carmignac Gestion's ResMed position peaked at $9.59M in Q4 2021.
  • 688 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Carmignac Gestion's 13F filing for Q4 2023, filed 13 Feb 2024.